Monday | Thursday | |||
---|---|---|---|---|
NAL parameters | n† | Median (range) | n | Median (range) |
*p=0.05,***p<0.01 significance level between Thursday and Monday (Wilcoxon signed rank test). | ||||
†Number of subjects. | ||||
‡Below detection limit of 2.0 ng/ml. | ||||
Total cells (×106/ml) | 29 | 0.174 (0–2.39) | 29 | 0.138 (0–1.30) |
Neutrophils (×106/ml) | 28 | 0.040 (0–0.93) | 26 | 0.067 (0.01–0.69) |
Epithelial cells (×106/ml) | 28 | 0.105 (0–1.59) | 26 | 0.084 (0–0.76) |
Eosinophils (×106/ml) | 28 | 0 (0–0.01) | 26 | 0 (0–0.02) |
Neutrophils (%) | 29 | 28 (4–92) | 28 | 46*** (7–86) |
Epithelial cells (%) | 29 | 73 (8–96) | 28 | 54 (14–94) |
Eosinophils (%) | 29 | 0 (0–1) | 28 | 0 (0–3) |
IL-8 (pg/ml) | 30 | 651 (0–3379) | 30 | 902 (0–4749) |
MPO (ng/ml) | 30 | 210 (0–2394) | 30 | 330 (21–2775) |
ECP (ng/ml) | 30 | 5.1 (<2‡–32.9) | 30 | 9.3* (<2.0–47.6) |